Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,272 | 8,881 | 5,007 | 6,184 | 7,245 |
| TOTAL | $10,081 | $9,150 | $5,222 | $6,429 | $7,560 |
| Non-Current Assets | |||||
| PPE Net | 20 | 19 | 23 | 16 | 7 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,129 | 11,173 |
| TOTAL | $11,168 | $11,167 | $11,171 | $11,145 | $11,181 |
| Total Assets | $21,249 | $20,317 | $16,393 | $17,574 | $18,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 108 | 296 | 298 | 432 |
| Accounts payable and accrued liabilities | 645 | 858 | 1,049 | 983 | 821 |
| Other current liabilities | 1,185 | 1,238 | N/A | N/A | N/A |
| TOTAL | $1,830 | $2,204 | $1,345 | $1,280 | $1,253 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 50 | 0 |
| Other Non-Current Liabilities | 0 | 1,846 | 0 | 0 | 0 |
| TOTAL | $150 | $1,971 | $88 | $50 | $N/A |
| Total Liabilities | $1,980 | $4,175 | $1,433 | $1,330 | $1,253 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9 | 8 | 8 | 5 | 5 |
| Common Shares | 21 | 18 | 12 | 12 | 11 |
| Retained earnings | -8,429 | -5,004 | -4,675 | -3,251 | -1,819 |
| Other shareholders' equity | -34 | 0 | 0 | -3 | -3 |
| TOTAL | $19,269 | $16,142 | $14,960 | $16,244 | $17,488 |
| Total Liabilities And Equity | $21,249 | $20,317 | $16,393 | $17,574 | $18,740 |